Die obstruktive Schlafapnoe im höheren Lebensalter

Die obstruktive Schlafapnoe (OSA) ist eine sehr häufige Gesundheitsstörung im höheren Lebensalter. Konservative Schätzungen gehen davon aus, dass etwa 20 % der älteren (65+) Allgemeinbevölkerung davon betroffen sind (1). Die Anzahl der Heimbewohner mit obstruktiver Schlafapnoe wird auf mehr als 70 % geschätzt (2, 3).

• Literatur

• 1 Young T, Shahar E. et al. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002; 162 (08) 893-900.
• 2 Ancoli-Israel S, Klauber MR, Kripke DF. et al. Sleep apnea in female patients in a nursing home. Increased risk of mortality. Chest 1989; 96 (05) 1054-1058.
• 3 Palmer S, Selvaraj S, Dunn C. et al. Annual review of patients with sleep apnea/hypopnea syndrome--a pragmatic randomised trial of nurse home visit versus consultant clinic review. Sleep medicine 2004; 5 (01) 61-65.
• 4 Shochat T. et al. Sleep Disorders in the Elderly. Current treatment options in neurology 2001; 3 (01) 19-36.
• 5 McMillan A. et al. Continuous positive airway pressure in older people with obstructive sleep apnoea syndrome (PREDICT): a 12-month, multicentre, randomised trial. The Lancet. Respiratory medicine 2014; 2 (10) 804-812.
• 6 Bloom HG. et al. Evidence-based recommendations for the assessment and management of sleep disorders in older persons. J Am Ger Soc 2009; 57 (05) 761-789.
• 7 Liu D, Myles H, Foley DL. et al. Risk Factors for Obstructive Sleep Apnea Are Prevalent in People with Psychosis and Correlate with Impaired Social Functioning and Poor Physical Health. Frontiers in psychiatry 2016; 7: 139.
• 8 He Y, Chen R, Wang J. et al. Neurocognitive impairment is correlated with oxidative stress in patients with moderate-to-severe obstructive sleep apnea hypopnea syndrome. Respiratory medicine 2016; 120: 25-30.
• 9 Martin MS, Sforza E, Crawford-Achour E. et al. Sleep breathing disorders and cognitive decline in healthy elderly followed for eight years: The PROOF cohort. Annals of physical and rehabilitation medicine 2016; 59S e99.
• 10 Werli KS. et al. Neurocognitive function in patients with residual excessive sleepiness from obstructive sleep apnea: a prospective, controlled study. Sleep Med 2016; 26: 6-11.
• 11 Karimi M, Hedner J, Zou D. et al. Attention deficits detected in cognitive tests differentiate between sleep apnea patients with or without a motor vehicle accident. Sleep medicine 2015; 16 (04) 528-533.
• 12 Celle S, Annweiler C. et al. Sleep-related breathing disorders and gait variability: a cross-sectional preliminary study. BMC pulmonary medicine 2014; 14: 140.
• 13 Stone KL, Blackwell TL, Ancoli-Israel S. et al. Sleep disturbances and risk of falls in older community-dwelling men: the outcomes of Sleep Disorders in Older Men (MrOS Sleep) Study. J Am Ger Soc 2014; 62 (02) 299-305.
• 14 Medeiros AKL, Coutinho RQ, Barros IML. et al. Obstructive sleep apnea is independently associated with subclinical coronary atherosclerosis among middle-aged women. Sleep & breathing. 2016
• 15 Acker J, Richter K, Piehl A. et al. Obstructive sleep apnea (OSA) and clinical depression-prevalence in a sleep center. Sleep & breathing. 2016
• 16 Endeshaw YW. Successful treatment of obstructive sleep apnea in a nonagenarian. J Am Ger Soc 2009; 57 (12) 2377-2378.
• 17 Redline S, Schluchter MD, Larkin EK, Tishler PV. Predictors of longitudinal change in sleep-disordered breathing in a nonclinic population. Sleep 2003; 26 (06) 703-709.
• 18 Bliwise DL. Epidemiology of age-dependence in sleep disordered breathing (SDB) in old age: The bay area sleep cohort (BASC). Sleep medicine clinics 2009; 4 (01) 57-64.
• 19 Sforza E, Gauthier M, Crawford-Achour E. et al. A 3-year longitudinal study of sleep disordered breathing in the elderly. Eur Resp J 2012; 40 (03) 665-672.
• 20 Mayer G, Arzt M, Braumann B, Ficker HJ. et al. S3-Leitlinie Nicht erholsamer Schlaf/Schlafbezogene Atmungsstörungen: S3 Leitlinie. Berlin: Springer; 2017
• 21 Netzer NCC, Ancoli-Israel SC, Bliwise DL. et al. Principles of practice parameters for the treatment of sleep disordered breathing in the elderly and frail elderly: the consensus of the International Geriatric Sleep Medicine Task Force. Eur Resp J 2016; 48 (04) 992-1018.
• 22 Baillieul S, Perennou D. et al. Impaired control of gait in patients with severe obstructive sleep apnea is reversed by continuous positive airway pressure treatment. Annals of physical and rehabilitation medicine 2016; 59S e118-e119.
• 23 Davies CR, Harrington JJ. Impact of Obstructive Sleep Apnea on Neurocognitive Function and Impact of Continuous Positive Air Pressure. Sleep Med Clin 2016; 11 (03) 287-298.
• 24 Deng G, Qiu Z, Li D. et al. Effects of continuous positive airway pressure therapy on plasma aldosterone levels in patients with obstructive sleep apnea: A meta-analysis. Journal of Huazhong University of Science and Technology. Medical sciences 2016; 36 (05) 619-625.
• 25 Joyeux-Faure M, Naegele B, Pepin J. et al. Continuous positive airway pressure treatment impact on memory processes in obstructive sleep apnea patients: a randomized sham-controlled trial. Sleep medicine 2016; 24: 44-50.
• 26 Lam JCM, Lai AYK, Tam TCC. et al. CPAP therapy for patients with sleep apnea and type 2 diabetes mellitus improves control of blood pressure. Sleep & breathing. 2016
• 27 Frohnhofen H, Hoeltmann B, Orth G. Acceptance of NCPAP in a sample of patients admitted for geriatric rehabilitation. Eur J Med Res 2009; 14 (Suppl. 04) 82-85.
• 28 Frohnhofen H, Mahl N. Maskenakzeptanz-Test (MAT) bei alteren Patienten mit obstruktiver Schlafapnoe. Laryngorhinootologie 2007; 86 (01) 6-7.